These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
192 related items for PubMed ID: 2435444
1. Fast anterograde axonal transport in wasted and non-wasted diabetic rats; effects of aldose reductase inhibition. Whiteley SJ, Townsend J, Tomlinson DR, Willars GB. Diabetes Res; 1986 Nov; 3(9):447-52. PubMed ID: 2435444 [Abstract] [Full Text] [Related]
2. Reduced anterograde and retrograde accumulation of axonally transported phosphofructokinase in streptozotocin-diabetic rats: effects of insulin and the aldose reductase inhibitor 'Statil'. Willars GB, Calcutt NA, Tomlinson DR. Diabetologia; 1987 Apr; 30(4):239-43. PubMed ID: 2439402 [Abstract] [Full Text] [Related]
3. Axonal transport and tissue contents of substance P in rats with long-term streptozotocin-diabetes. Effects of the aldose reductase inhibitor 'statil'. Robinson JP, Willars GB, Tomlinson DR, Keen P. Brain Res; 1987 Nov 24; 426(2):339-48. PubMed ID: 2446712 [Abstract] [Full Text] [Related]
4. Treatment with an aldose reductase inhibitor can reduce the susceptibility of fast axonal transport following nerve compression in the streptozotocin-diabetic rat. Dahlin LB, Archer DR, McLean WG. Diabetologia; 1987 Jun 24; 30(6):414-8. PubMed ID: 2445613 [Abstract] [Full Text] [Related]
5. Slow orthograde axonal transport of radiolabelled protein in sciatic motoneurones of rats with short-term experimental diabetes: effects of treatment with an aldose reductase inhibitor or myo-inositol. Mayer JH, Tomlinson DR, McLean WG. J Neurochem; 1984 Nov 24; 43(5):1265-70. PubMed ID: 6208327 [Abstract] [Full Text] [Related]
6. Studies on peripheral nerve and lens in long-term experimental diabetes: effects of the aldose reductase inhibitor statil. Willars GB, Townsend J, Tomlinson DR, Compton AM, Churchill RD. Metabolism; 1988 May 24; 37(5):442-9. PubMed ID: 2452959 [Abstract] [Full Text] [Related]
7. Prevention of defects of axonal transport and nerve conduction velocity by oral administration of myo-inositol or an aldose reductase inhibitor in streptozotocin-diabetic rats. Mayer JH, Tomlinson DR. Diabetologia; 1983 Nov 24; 25(5):433-8. PubMed ID: 6197336 [Abstract] [Full Text] [Related]
8. Slow component-a of axonal transport, nerve myo-inositol, and aldose reductase inhibition in streptozocin-diabetic rats. Tomlinson DR, Sidenius P, Larsen JR. Diabetes; 1986 Apr 24; 35(4):398-402. PubMed ID: 2420664 [Abstract] [Full Text] [Related]
9. Increased nerve polyol levels in experimental diabetes and their reversal by Sorbinil. Whiting PH, Ross IS. Br J Exp Pathol; 1988 Oct 24; 69(5):697-702. PubMed ID: 3143396 [Abstract] [Full Text] [Related]
10. Prevention of defective axonal transport in streptozocin-diabetic rats by treatment with "Statil" (ICI 128436), an aldose reductase inhibitor. Tomlinson DR, Townsend J, Fretten P. Diabetes; 1985 Oct 24; 34(10):970-2. PubMed ID: 2412918 [Abstract] [Full Text] [Related]
11. Properties of ICI 128,436, a novel aldose reductase inhibitor, and its effects on diabetic complications in the rat. Stribling D, Mirrlees DJ, Harrison HE, Earl DC. Metabolism; 1985 Apr 24; 34(4):336-44. PubMed ID: 3920474 [Abstract] [Full Text] [Related]
12. The effect of aldose reductase inhibition on the pattern of nerve conduction deficits in diabetic rats. Cameron NE, Cotter MA, Robertson S. Q J Exp Physiol; 1989 Nov 24; 74(6):917-26. PubMed ID: 2512591 [Abstract] [Full Text] [Related]
13. Axonal transport and nerve conduction and their relation to nerve polyol and myo-inositol levels in spontaneously diabetic BB/D rats. Mayer JH, Herberg L, Tomlinson DR. Neurochem Pathol; 1989 Nov 24; 2(4):285-93. PubMed ID: 6085698 [Abstract] [Full Text] [Related]
14. Effect of aldose reductase inhibition on nerve conduction velocity and resistance to ischemic conduction block in experimental diabetes. Price DE, Airey CM, Alani SM, Wales JK. Diabetes; 1988 Jul 24; 37(7):969-73. PubMed ID: 3133261 [Abstract] [Full Text] [Related]
15. Sorbitol metabolism in the retina, optic nerve, and sural nerve of diabetic rats treated with an aldose reductase inhibitor. Naeser P, Brolin SE, Eriksson UJ. Metabolism; 1988 Dec 24; 37(12):1143-5. PubMed ID: 3143049 [Abstract] [Full Text] [Related]
16. The effects of an aldose reductase inhibitor upon the sorbitol pathway, fructose-1-phosphate and lactate in the retina and nerve of streptozotocin-diabetic rats. Poulsom R, Mirrlees DJ, Earl DC, Heath H. Exp Eye Res; 1983 May 24; 36(5):751-60. PubMed ID: 6406254 [Abstract] [Full Text] [Related]
17. The effect of aldose reductase inhibitor, statil, on hyperpermeability of iridial vessels in experimental galactosemic rats. Terubayashi H, Akagi Y. Jpn J Ophthalmol; 1989 May 24; 33(3):343-7. PubMed ID: 2507812 [Abstract] [Full Text] [Related]
18. Correction of nerve conduction and endoneurial blood flow deficits by the aldose reductase inhibitor, tolrestat, in diabetic rats. Cotter MA, Cameron NE, Hohman TC. J Peripher Nerv Syst; 1998 May 24; 3(3):217-23. PubMed ID: 10959252 [Abstract] [Full Text] [Related]
19. Streptozotocin-induced diabetes causes metabolic changes and alterations in neurotrophin content and retrograde transport in the cervical vagus nerve. Lee PG, Hohman TC, Cai F, Regalia J, Helke CJ. Exp Neurol; 2001 Jul 24; 170(1):149-61. PubMed ID: 11421592 [Abstract] [Full Text] [Related]
20. Ultrastructural observations on myelinated fibres in experimental diabetes: effect of the aldose reductase inhibitor ponalrestat given alone or in conjunction with insulin therapy. Bhoyrul S, Sharma AK, Stribling D, Mirrlees DD, Peterson RG, Farber MO, Thomas PK. J Neurol Sci; 1988 Jun 24; 85(2):131-47. PubMed ID: 2968441 [Abstract] [Full Text] [Related] Page: [Next] [New Search]